![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1747592
È»ó ¿¬°í ½ÃÀå : Á¦Ç° À¯Çüº°, È»ó ±íÀ̺°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°Burn Ointment Market, By Product Type, By Depth of Burn, By End User, By Geography |
È»ó ¿¬°í ½ÃÀåÀº 2025³â¿¡´Â 11¾ï 6,060¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 17¾ï 5,670¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â CAGR 6.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
º¸°í ¹üÀ§ | º¸°í¼ ¼¼ºÎÁ¤º¸ | ||
---|---|---|---|
±âÁØ ¿¬µµ | 2024³â | ½ÃÀå ±Ô¸ð(2025³â) | 11¾ï 6,060¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2020-2024³â | ¿¹Ãø ±â°£ | 2025-2032³â |
¿¹Ãø ±â°£ CAGR(2025-2032³â) : | 6.10% | °¡Ä¡ ¿¹Ãø(2032³â) | 17¾ï 5,670¸¸ ´Þ·¯ |
È»óÀº ¿, ÈÇй°Áú, ÇÞºû, ¹æ»ç¼± µî¿¡ ÀÇÇØ ÇǺÎÁ¶Á÷ÀÌ ¼Õ»óÀ» ÀÔ´Â °ÍÀ¸·Î ¹ß»ýÇÕ´Ï´Ù. È»óÀÇ ´ëºÎºÐÀº »ç°í°¡ ¿øÀÎÀÔ´Ï´Ù. È»óÀº Á¦1µµ, Á¦2µµ, Á¦3µµ µî ´Ù¾çÇÑ Á¤µµ°¡ ÀÖ½À´Ï´Ù. Á¦1µµ È»óÀº °æÁõÀÔ´Ï´Ù(´ëºÎºÐÀÇ ¼±Åİú µ¿ÀÏ). ÇǺÎÀÇ ¸Ç ÀÃþ(Ç¥ÇÇ)ÀÌ ºÓ¾îÁö°í ÅëÁõÀ» µ¿¹ÝÇÏÁö¸¸, º¸ÅëÀº ¹°ÁýÀÌ µÇÁö ¾Ê½À´Ï´Ù. Á¦2µµ È»óÀº ÇǺÎÀÇ ÃÖ»óÃþ°ú ÃÖÇÏÃþ(ÁøÇÇ)ÀÌ Ä§¹üÇÕ´Ï´Ù. µ¿Åë, ¹ßÀû, Á¾Ã¢, ¼öÆ÷ Çü¼ºÀº ¸ðµÎ ÀϾ ¼ö ÀÖ´Â ºÎÀÛ¿ëÀÔ´Ï´Ù. Á¦3µµ È»óÀº ÇǺÎÀÇ Ç¥ÇÇ, ÁøÇÇ, Áö¹æÀÇ 3Ãþ ¸ðµÎ¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.
È»ó ¿¬°í´Â È»ó ºÎÀ§¿¡ µµÆ÷ÇÏ´Â ±¹¼Ò Åõ¿© Ä¡·áÁ¦·Î Á©, Å©¸², ¿ÀÀÏ, ½ºÇÁ·¹ÀÌ µîÀÇ ÇüÅ·ΠÀÔ¼öÇÒ ¼ö ÀÖ½À´Ï´Ù. È»ó »óó¸¦ ¹°·Î ½ÄÈù ÈÄ È»ó ¿¬°í¸¦ µµÆ÷ÇÏ¿© Ä¡·áÇÕ´Ï´Ù. ¿¬°íÀÇ Á¾·ù´Â ¿»óÀÇ Á¤µµ¿¡ µû¶ó ´Þ¶óÁý´Ï´Ù. ¿¹¸¦ µé¾î, °¡Á¤¾àÀ¸·Î ¾Ë·Î¿¡ º£¶ó Á©À» »ç¿ëÇÏ¿© È»óÀ» Ä¡·áÇÏ´Â »ç¶÷µµ ÀÖ½À´Ï´Ù. ÇÑÆí, È»ó Ä¡·á¿¡´Â Ç×»ýÁ¦°¡ µé¾î ÀÖ´Â Å©¸²ÀÌ »ç¿ëµË´Ï´Ù. ÇÏÁö¸¸ Á¦2µµ³ª Á¦3µµ È»ó Ä¡·á¿¡´Â ¼¼±Õ °¨¿° °¡´É¼ºÀ» ¸·±â À§ÇØ ÇコÄÉ¾î °ø±ÞÀÚ°¡ ¼úÆÄµð¾ÆµòÀº µî ÀºÀ» ÇÔÀ¯ÇÑ ´õ °·ÂÇÑ Ç×»ýÁ¦ Å©¸²À» ó¹æÇÒ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå °³Ã´ÀÚ´Â È»ó°ú °ü·ÃµÈ ½ÅÁ¦Ç° ¹× ½Å±â¼úÀÇ ½ÂÀÎ ÃëµæÀ» À§ÇÑ ¿¬±¸°³¹ß Ȱµ¿¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, À̰ÍÀÌ ¿¹Ãø ±â°£ Áß ¼¼°è È»ó ¿¬°í ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¸é, 2020³â 10¿ù, Recce Pharmaceuticals Ltd´Â, °¨¿°µÈ È»óâÀÇ È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ ±¤¿ª Ç×»ý ¹°Áú RECCE 327ÀÇ Á¦I/II»ó ÀÓ»ó ½ÃÇèÀ» °³½ÃÇϱâ À§ÇÑ Àΰ£ ¿¬±¸ À±¸® À§¿øÈ¸(HREC)ÀÇ ½ÂÀÎÀ» ÃëµæÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.
½ÃÀå °¢»ç´Â Á¦Ç°ÀÇ Ãâ½Ã¿¡ ÁÖ·ÂÇϰí ÀÖ¾î ¼¼°èÀÇ È»ó ¿¬°í ½ÃÀå¿¡ ÀÖ¾î¼ ÁöÀ§ °È°¡ ±â´ëµË´Ï´Ù. ¿¹¸¦ µé¾î 2020³â 5¿ù 1ÀÏ ½ºÅ²ÄÉ¾î ¾÷°èÀÇ »õ·Î¿î ÇコÅ×Å© Ç÷¹À̾îÀÎ ¸£¸¶¼ÖÀº ±× ù ¹øÂ° Á¦Ç°ÀÎ ¸£¸¶¼ÖÀ» Ãâ½ÃÇß½À´Ï´Ù. ¸£¸¶¼ÖÀº ÇÞºµ¿¡ Ÿ°Å³ª ³ëÈ µî ÅÂ¾ç °ü·Ã ÁúȯÀ» ¿¹¹æÇÏ´Â µ¥ µµ¿òÀ» ÁÖ´Â µ¶Æ¯ÇÏ°í ¹ÝÅõ¸íÇÏ°í ¹«ÂüÇÑ Ã³¹æÀÇ ±¤¿ª ½ºÆåÆ®·³ SPF 50 ¹Ì½ºÆ®ÀÔ´Ï´Ù.
½ÃÀå ±â¾÷Àº Àμö ¹× ÆÄÆ®³Ê½Ê°ú °°Àº Àü·«À» äÅÃÇÔÀ¸·Î½á ¼¼°èÀÇ Á¸À縦 È®´ëÇÏ´Â µ¥ °ü¿©Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°èÀûÀ¸·Î È»ó »óó ¿¬°í ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î 2019³â 5¿ù ¹Ì±¹ ¹ÙÀÌ¿ÀÀǾàǰ ȸ»çÀÎ Vericel CorporationÀº ¿ÏÀü ÅëÇÕÇü ¹ÙÀÌ¿ÀÀǾàǰ ȸ»çÀÎ MediWound Ltd.¿Í µ¿»çÀÇ NexoBrid »ý¹°ÇÐÀû Á¦Á¦¿¡ °üÇÑ ¹Ì±¹¿¡¼ÀÇ µ¶Á¡Àû ¶óÀ̼¾½º ¹× °ø±Þ °è¾àÀ» ü°áÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.
Burn Ointment Market is estimated to be valued at USD 1,160.6 Mn in 2025 and is expected to reach USD 1,756.7 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 1,160.6 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 6.10% | 2032 Value Projection: | USD 1,756.7 Mn |
A burn occurs when skin tissue is damaged by heat, chemicals, sunlight, electricity, or radiation. The majority of burns are caused due to accidents. There are various degrees of burns- first degree, second degree and third degree burns. First-degree burns are minor (like most sunburns). The top layer of skin (epidermis) turns red and painful, but it usually does not blister. Second-degree burns affect the top and bottom layers of the skin (dermis). Pain, redness, swelling, and blistering are all possible side effects. Third-degree burns affect all three layers of the skin: the epidermis, dermis, and fat.
Burn ointment is a topically administered treatment applied on the burnt area of our body and is available in the form of gels, creams, oils and sprays. After cooling the burn injury with water, burn ointments are applied to heal the burn wounds. The types of ointment used depends upon the severity of burns. For example, some people use aloe vera gel as a home remedy to treat sunburns. While antibiotic creams are used to treat thermal burns. However, for the treatment of second and third degree burns, the healthcare provider may prescribe a stronger antibiotic cream containing silver, such as silver sulfadiazine, to prevent possible bacterial infections.
Market players are focused on research and development activities to obtain approvals for new products or techniques associated with burn injuries, which could contribute to the growth of the global burn ointment market over the forecast period. For instance, in Oct 2020, Recce Pharmaceuticals Ltd announced that it has received Human Research Ethics Committee (HREC) approval to begin a Phase I/II clinical trial of its broad-spectrum antibiotic RECCE 327 on patients with infected burn wounds.
Market players are focusing on product launches, which is expected to strengthen their position in the global burn ointment market. For instance, on May 1, 2020, LUMASOL, a new health tech player in the skincare industry, launched its first product lumasol, a broad-spectrum SPF 50 mist with a unique, translucent, and cruelty-free formula that helps prevent sun-related disease such as sunburns and ageing.
Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the global burn ointment market globally. For instance, in May 2019, Vericel Corp., an American biopharmaceutical company announced an exclusive U.S. licensing and supply agreement with MediWound Ltd., a fully-integrated biopharmaceutical company for its NexoBrid biological product.